LRRC4B and breast carcinoma: In the DRIVE RNAi screen, nearly all breast cancer cell lines displayed significantly increased cell viability upon LRRC4B knockdown (Supplementary Figure S6A) and breast cancers in TCGA showed lower LRRC4B expression compared to normal breast tissue (Supplementary Figure S6B).